Drugs / acenocumarol
last change Dec 2017 re-read 2 minutes ago

acenocumarol

Developed for
antiphospholipid syndrome

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02926170 Comparator Mar 2013 → Dec 2017 antiphospholipid syndrome Hospital Universitari Vall d'Hebron Research Institute Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as acenocumarol ClinicalTrials.gov intervention name — accepted as the source's own label NCT02926170